UHRF1 and cancer: These data are consistent with the absence of a DNA methylation defect after treatment with the LIG1K126me2-CPP (Fig. 3d) and further confirm that LIG1 does not contribute to UHRF1-dependent DNA methylation maintenance in bulk cancer cell populations.